The AI in Business Podcast
AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte
Podcast
The AI in Business Podcast
Datum
23/02/2024
Episode #null mit:
Alle Episoden anzeigen
Today’s guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to talk about challenges in R&D for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.
Ähnliche Podcasts
Künstliche Intelligenz
Big Technology Podcast
Will AI Really Take Our Jobs? And If So, Then What? — With Albert Wenger
Customer Service
Künstliche Intelligenz
Wirtschaftsinformatik
The AI in Business Podcast
Generative AI for Healthcare - with Dr. Dan Elton of Mass General Brigham
The AI in Business Podcast
Opportunities for AI in Private Equity - with Bhuvanesh Abrol of Deloitte
Generative AI
The AI in Business Podcast
What GenAI Means for Life Sciences IT Leaders - with Steven Zhang of Deloitte